Document Detail


Biphasic effect of a primary tumor on the growth of secondary tumor implants.
MedLine Citation:
PMID:  20700688     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The phenomenon of hormesis is characterized by a biphasic dose-response, exhibiting opposite effects in the low- and high-dose zones. In this study, we explored the possibility that the hormesis concept may describe the interactions between two tumors implanted in a single mouse, such that the resulting tumors are of different sizes. MATERIALS AND METHODS: We used two murine tumors of spontaneous origin and undetectable immunogenicity growing in BALB/c mice. A measure of cell proliferation was obtained by immunostaining for Ki-67 protein and by using the [(3)H] thymidine uptake assay. For serum fractionation, we utilized dialysis and chromatography on Sephadex G-15. RESULTS: The larger primary tumor induced inhibitory or stimulatory effects on the growth of the smaller secondary one, depending on the ratio between the mass of the larger tumor relative to that of the smaller one, with high ratios rendering inhibition and low ratios inducing stimulation of the secondary tumor. CONCLUSION: Since metastases can be considered as natural secondary tumor implants in a tumor-bearing host and that they constitute the main problem in cancer pathology, the use of the concept of hormesis to describe those biphasic effects might have significant clinical implications. In effect, if the tumor-bearing host were placed in the inhibitory window, tumor extirpation could enhance the growth of distant metastases and, reciprocally, if placed in the stimulatory window, tumor extirpation would result not only in a reduction or elimination of primary tumor load but also in a slower growth or inhibition of metastases.
Authors:
Juan Bruzzo; Paula Chiarella; Roberto P Meiss; Raúl A Ruggiero
Related Documents :
7306998 - Effect of tumors on the concentration of leucogenenol in the serum of mice.
6850578 - Host cathepsin d response to tumor in the normal and pepstatin-treated mouse.
6446378 - Characterization of immunosuppressor cells in rats immunized with solubilized tumor-ass...
15262898 - Bryostatin 1/ionomycin (b/i) ex vivo stimulation preferentially activates l-selectinlow...
21797138 - Tumor dissemination after laparoscopic surgery for an unsuspected endometrial stromal t...
12479268 - Molecular inhibition of angiogenesis and metastatic potential in human squamous cell ca...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-02-21
Journal Detail:
Title:  Journal of cancer research and clinical oncology     Volume:  136     ISSN:  1432-1335     ISO Abbreviation:  J. Cancer Res. Clin. Oncol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-08-11     Completed Date:  2010-09-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902060     Medline TA:  J Cancer Res Clin Oncol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1605-15     Citation Subset:  IM    
Affiliation:
División Medicina Experimental (ILEX-CONICET), Academia Nacional de Medicina de Buenos Aires, Pacheco de Melo 3081, 1425 Buenos Aires, Argentina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Proliferation
Ki-67 Antigen / analysis
Male
Mice
Mice, Inbred BALB C
Neoplasm Metastasis
Neoplasm Transplantation
Neoplasms, Experimental / blood,  pathology*
Neoplasms, Second Primary / pathology*
Chemical
Reg. No./Substance:
0/Ki-67 Antigen; 0/Mki67 protein, mouse

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Identification of proteins responsible for the multiple drug resistance in 5-fluorouracil-induced br...
Next Document:  NMR with (13)C, (15)N-doubly-labeled DNA: The shape Antennapedia homeodomain complex with a 14-mer D...